Neuropharmacology Conference | Neuroscience Conference | Psychology drugs | Psychiatry events | Pharmacology Conferences | Pharmacology 2023 | Pharma events 2023 | Pharmaceutical | Pharma Conferences | Europe | USA | Middle East

Pharmacology conferences, Pharmacology 2023, Pharmacology Congress 2023, international pharmacology Conferences, pharmacology forum, international pharmacology conference 2023, pharmacology meetings, Pharmacology Conferences 2023 Asia, Neuroscience

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Alzheimers-2025, France NEUROSCIENCE_2025, France Stroke Meeting 2025, France Euro Dementia 2025, Germany Mental Health Congress 2025, France

Asia Pacific & Middle East

Neurology Surgery 2024, UAE Neurology 2024, UAE

Canada

Neuro Experts 2023, Canada NEURODISORDERS CONGRESS 2023, Canada Psychotherapy Conference 2023, Canada

Neuropharmacology_2023

About Neuropharmacology

It is our immense pleasure and honour to welcome all the Scientific Experts, Academicians, Doctors, Business Delegates and Researchers, Business Clients and all the students at our esteemed 29th Global Experts Meeting on Neuroscience and Neuropharmacology for productive interactions and an opportunity to present their work and develop regional collaborations in the field of Neurology.

Conference Date & Venue: October 25-26, 2023 | Webinar

Theme: Neural Dynamics: Integrating Neuropharmacology and Neuroscience for Enhanced Therapies

It aspires to conduct the survey and examine in reverend fields of Neurology and Pharmacology and to put forward the past and current research by academicians and practitioners from multiple disciplines to debate and deliberate on social change progress and the latest trends at different level that well harmonizes to life sciences.

World renowned scientists, Noble Laureates and Scholars in their respective fields are part of our conference as keynote speakers, panel experts, and organizing committee members for this conference.

Why to attend?

Neuropharmacology 2023 is an unique venture which will bring together experts like Neuroscientists, Pharmacologists, Clinicians, Neurogenetics, Neurologists, Psychiatrists, Medical practitioners, Care specialists, academic professionals and students from all over the world to share and exchange estimations to the massive audience and also an endeavour and to spread technical, research advances in the clinical, diagnostic and physiological aspects of Neurology. This conference meeting will create a best stage for participants to find out about the current innovations in the field of neurology and neuroscience.

Target Audience

Neurologists, Neuroscience Institutions, Healthcare professionals, Doctors, Educational institutions, Nurses, Pharmaceutical companies and industries, Clinical organizations, Psychiatrists, Neuropsychologists, Business delegates, Young researchers and Students, Industrialist, other expert caretakers of patients and all researchers in the field of Neurology

Sessions/Tracks

Track 1: Neuroscience

Neuroscience is a branch of science which deals with the study of structure and function of the brain and nervous system. It includes different approaches used to study the nervous system at the different scales and the techniques. It focuses on all aspects of how the system functions including the structure and development of the body and it’s where psychology meets biology.

Track 2: Neurophysiology

Neurophysiology is the physiology of the nervous system and it is the primary tools of basic neurophysiological research which include electrophysiological recordings, such as extracellular single-unit recording local field potentials, patch clamp and recording of voltage clamp , as well as some of the methods of optogenetics, molecular biology, and calcium imaging. It features a broad interdisciplinary scope on systematic, cellular, and molecular neurophysiology, neurochemistry and functional neuromorphology.

Track 3: Cognitive Neuroscience

Cognitive neuroscience is one of the scientific fields that are concerned with the study of the biological processes and to study how brain enables the mind. Cognitive neuroscience includes two domains that known modes of neuronal processing and it maps higher-level cognitive functions to known brain architectures. It also explores how individual neurons operate and communicate to form complex neuronal architectures that comprise the human brain.

Track 4: Neuropathology

Neuropathology is the branch of medicine concerned with diseases of the nervous system and it is the study of central and peripheral nervous tissue in adults and children. The primary concern is the diagnosis of brain tumours, and neuropathologists are often able to give a preliminary diagnosis to the neurosurgeon while the patient is still on the operating table. It involves interpretation of molecular tests and special stains and will guide other members of the multidisciplinary team when deciding upon treatment strategies. Neuropathologists look at muscle to diagnose inherited and acquired muscle diseases, alongside peripheral nerve samples and occasionally ophthalmic specimens and they are also responsible for post-mortem brain analysis.

Track 5: Neurocardiology

Neurocardiology refers to the pathophysiological interplays of the cardiovascular and nervous systems. It is the study of neurological, neurophysiological and neuroanatomical aspects of cardiology including the neurological origins of cardiac disorders. The neurocardiac axis links the cardiovascular and nervous systems to physiological problems such as: stroke, epilepsy and arrhythmias. Clinical issues in Neurocardiology include neurogenic stress cardiomyopathy, cardiovascular findings in patients with primary neurological disease, neurologic sequelae of cardiac and thoracic surgery and cardiac interventions and hypoxic-ischemic brain injury.

Track 6: Neurogenetics

Neurogenetics is the study of role of genetics in the function and development of the nervous system that it will draw all the aspects from both the studies of neuroscience and genetics mainly focusing on genetic codes i.e., traits, Mutations where in this genetic sequence can have a wide range of effects on the quality of life of the individual.

Tracks 7: Vascular Dementia

Vascular Dementia is caused by an impaired supply of blood to the brain which may be caused by a series of small strokes. This condition causes changes in thinking skills, memory, speech or balance these conditions can get worse over time or it can happen suddenly or begin mildly. It is also known as vascular cognitive impairment (VCI) and multi infract dementia (MID).

Tracks 8: Autonomic Neurology

Autonomic Neurology focuses on presentation of clinical cases and clinical scenarios. The anatomical and biochemical mechanisms of central and peripheral nervous system control of autonomic function, a clinical and laboratory approach to the diagnosis of autonomic disorders, and principles of autonomic pharmacology. It focuses on the pathophysiology and management of disorders of sweating, neurogenic bladder, gastrointestinal dysmotility, and autonomic hyperactivity. Mainly it is devoted to specific autonomic disorders, including common peripheral neuropathies and central neurodegenerative disorders with prominent autonomic failure, painful small fibre neuropathies, focal brain disorders, focal spinal cord disorders, and chronic pain disorders with autonomic manifestations.

Tracks 9: Computational Neurology

Computational Neurology is a branch of neuroscience which employs abstractions, theoretical analysis and mathematical models of the brain to understand the principles that govern the cognitive abilities, development, physiology and structure of the nervous system. Topics including representation of information by spiking neurons, algorithms for adaptation and learning and processing of information in neural networks are studied, Computational Neurology is also known as theoretical neuroscience or mathematical neuroscience.

Track 10: Neuropediatrics and Neurorehabilitation

The study of relationship between brain health and behaviour in children is referred as Neuropediatrics which is a sub-speciality within the field of clinical neuropsychology. The complex medical process aims to aid recovery from a nervous system injury is known as Neurorehabilitation.

Track 11: Neurosurgery and Neural Circuits

Neurosurgery is concerned with the rehabilitation of disorders, diagnosis and surgical treatment which may affect any portion of the nervous system. The neurosurgery is required to treat the underlying cause of back pain as opposed to conservative treatments by discectomy or laminectomy. Neural circuits are population of neurons which are interconnected by synapses and will carry out specific functions when they are activated.

Tracks 12: Neuroscience Behind the Placebo Effect

Placebo Effect is a beneficial effect produced by a treatment or placebo drug. Emerging research n the field of neuroscience evidence implicates on neurochemical mediators and multiple brain systems including dopamine and opioids. The empirical review of the brain systems that are involved in placebo effects are presented, that focuses on a conceptual framework and placebo analgesia and linking these findings to the mind–brain processes that mediate them.

Track13: The Science of Neurotheology

The neuroscience of religion or Neurotheology is also known as spiritual neuroscience refers to the multidisciplinary field of scholarship to understand the relationship between the religion and human brain. The evolutionary basis for subjective experiences traditionally categorized as spiritual or religious The field has tried to explain religious experience and behavior in neuroscientific terms.

Track 14: Stem cell approach for Neurological Disorders

Stem cell is an undifferentiated cell which has the capacity to give rise to a new cell and also to indefinitely more cells of the same type from which certain other kinds of cell arise by differentiation. It is showed by researchers that these cells are capable in the treatment of Neurological Disorders such as Alzheimer disease, Battens disease, Parkinson and many other neurological disorders and they can also be used for treatment of Spinal cord injury.

Track15: Neurotoxicology

Neurotoxicity is a form of toxicity in which a biological, chemical, or physical agent produces an adverse effect on the structure or function of the central and/or peripheral nervous system. The term neurotoxicity implies the involvement of a neurotoxin; however, the term neurotoxic may be used more loosely to describe states that are known to cause physical brain damage, but where no specific neurotoxin has been identified.

Track 16 : Neuromarketing

Neuromarketing is a new and a different method of marketing where they use medical technologies such as functional Magnetic Resonance Imaging (fMRI) to study the responses in brain to analyse for marketing stimuli. To measure or to analyse changes in activity of the brain and parts of brain and to learn why consumers make the decisions researchers use the fMRI and they also check what part of the brain is telling them to do.

Track 17: Clinical Trials and Case Reports

In recent decades the understanding of neurological diseases by physicians tend to approach disease and diagnose as if they were immutable. More than about 600 neurological diseases are found which occur due to injuries to spinal cord or brain or because of faulty gene. The practice of neurology is moving forward because of the importance of case reports special case issues, semiology, pathophysiology and present cases that provide glimpses into diagnosis

Market Analysis

Importance and Scope Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, cotransporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

It is necessary to focus Neurochemistry and Neuropharmacology and the use of neuropharmaceuticals to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people.

Comparative analysis for Neurological Disorders (Age wise profile)

Hospitals of Neuropharmacology

Mayo Clinic, Rochester, Minnesota

Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston

University of California–San Francisco Medical Center

Mathodist Hospital, San Antonio

University of California–Los Angeles Medical Center

New York University Langone Medical Center, New York City

Hospitals of the University of Pennsylvania–Penn Presbyterian

Northwestern Memorial Hospital, Chicago

Baptist Medical Centre, San Antonio

Major Neurochemistry and Neuropharmacology Associations related around the Globe

ERA NET Neuran

Volkswagon Stifung Foundation

American National Science and Education Fund

Vienna science and Technology fund

Snota Restaviel National Science Foundation

CORDIS

Massachusetts General Hospital Bost

Duras Neuroscience Center Florida

UCLLA Brain Research Institute California

ASN, American Society for Neurochemistry

International Society for Neurochemistry (ISN)

European neurochemistry society

Asian-Pacific Society for Neurochemistry

Canadian Neurological Sciences Federation

European Parkinson’s disease Association

Malaysian Society of Neurosciences

Eurospine, The Spine Society Of Europe

The Spanish Society of Neurology (SEN)

The Czech Neuropsychopharmacological Society

Belgian Neurological Society

National Neurotrauma Society

National Parkinson'S Foundation

European Society Of Neurosonology And Cerebral Hemodynamics

Federation Of European Neuroscience Societies

Malaysian Society Of Neurosciences

ÄŒeská Neurologická SpoleÄnost

The Czech Neuropsychopharmacological Society

European Academy Of Neurology

Deutsche Gesellschaft Fur Neurologieologie

International Brain Research Organization

The Neuropathy Association

The Primary Care Neurology Society

The Spanish Society Of Neurology (SEN)

Major Neuropharmacology related Associations

International Neuroethics Society

Society for Behavioral Neuroendocrinology

Society For Neuroscience

American Psychological Association

International Parkinson and Movement Disorder Society

American Neurological Association

National Institute Of Environmental Health Sciences

The American Society of Neuroimaging

American Board Of Psychiatry And Neurology, Inc.

American Clinical Neurophysiology Society

International Neuropsychological Society

Southern Clinical Neurological Society

International Parkinson And Movement Disorder Society

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuropharmaceutical related companies

Market Capitalization of Neuropharmaceutical companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Sales Profile of Neuropharmaceutical companies

Research Fund: NIH (National Institute of Health) and NSFC (Nature Science Foundation of China) provided fund for the neurological disorders such as dementia, schizophrenia, stroke, parkinson’s, epilepsy.

Institutes funding for research

1) The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universitat Pompeu Fabra, Barcelona

2) Neuropharmacology Program, The National Institute of Mental Health (NIMH)

3) McKnight Endowment Fund for Neuroscience

The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

Past Conference Report

Neuropharmacology 2022

Neuropharmacology 2022 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2022 Conference the best ever!

The 28th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series LLC Ltd was held during October 10-11, 2022 at Vienna, Austria on the theme “Novel Medical / Surgical Techniques and Promising Drugs usage in Central Nervous System". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Know more at Neuropharmacology 2022 Proceedings

Conference Series LLC Ltd expresses its gratitude to the conference Moderator and Chair namely Dr. Philip Timms , Dr. Wilfried Dimpfel for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Hari Shanker Sharma, Uppsala University, Sweden
Mehrdad Shamloo, Stanford University, USA

We are grateful to our Speakers of Special session. The list comprises:

Wilfried Dimpfel, Justus Liebig University Giessen, Germany
Olga Malyshevskaya, Tsukuba University, Japan
Kudret Esen Gumuslu, Kocaeli University, Turkey
Aruna Sharma, Uppsala University, Sweden
Eva Kudova, Institute of Organic Chemistry and Biochemistry – ASCR, Czech Republic

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Neuroimmunology and Neuroinflammation
Clinical Neuropharmacology
Neurochemical Transmission
Molecular Neuropharmacology
Parkinson’s Disease
Alzheimer’s Disease and Dementia
Psychopharmacology
Behavioral and Addiction Neuropharmacology
Neural Stem Cell
Neuroethics
Neurotechnology and its Advances
Neuroendocrinology
Future Aspects of Neuropharmacology

With the grand success of Neuropharmacology 2022, Conference Series LLC Ltd is proud to announce the " 29th Global Experts Meeting on Neuropharmacology" to be held during October 25-26, 2023, 2023 in Webinar

For More details visit: https://neuro.pharmaceuticalconferences.com/

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date October 25-26, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Neuropharmacology 2022 Conference

Supported By

Journal of Neuroscience and Neuropharmacology Neurological Disorders Research & Reviews: Neuroscience

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Neuroscience and Neuropharmacology

October 25-26, 2023 Webinar

Neural Dynamics: Integrating Neuropharmacology and Neuroscience for Enhanced Therapies

Neuropharmacology Conference | Neuroscience Conference | Psychology drugs | Psychiatry events | Pharmacology Conferences | Pharmacology 2023 | Pharma events 2023 | Pharmaceutical | Pharma Conferences | Europe | USA | Middle East | 2023

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Neuropharmacology_2023

About Neuropharmacology

Sessions/Tracks

Market Analysis

Hospitals of Neuropharmacology

Major Neurochemistry and Neuropharmacology Associations related around the Globe

Major Neuropharmacology related Associations

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Keytopics